Establishment of a multidrug resistance cell line A549/cDDP of human lung adenocarcinoma and expression analysis of multidrug resistance-associated genes

Chinese Journal of Lung Cancer

Volumn 12, Issue 3, 2009, Pages 187-192

  Pan, Yongcheng ^a   Zhao, Weigang ^a   Wang, Jianjun ^a   Liu, Quan ^a   Yang, Guanghai ^a   Li, Jinsong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gene expression; Lung neoplasmas; Multiple drug resistance

Indexed keywords

CISPLATIN; GLUTATHIONE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; LUNG ADENOCARCINOMA; MDR GENE; MRP GENE; MULTIDRUG RESISTANCE; NITROBLUE TETRAZOLIUM TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 66749116140     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2009.03.002     Document Type: Article

References (13)

1. Mese H, Sasaki A, Nakayama S, et al. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose starved stress in cisplatin - sensitive and resistant A431 cell line. Anticancer Res, 2001, 21(2A): 1029-1033.
2. Saito K, Khan K, Yu SZ, et al. The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer. Laryngoscope, 2008, 119(1): 82-88.
3. Lo M, Tsao MS, Hedley D, et al. Gene expression profiling of adenosine triphosphate-binding cassette transporters in response to K-ras activation and hypoxia in human pancreatic cancer cell cultures. Pancreas, 2009, 38(1): 85-93.
4. Scherm B, Schmoll M, Balmas V, et al. Identification of potential marker genes for Trichoderma harzianum strains with high antagonistic potential against Rhizoctonia solani by a rapid subtraction hybridization approach. Curr Genet, 2009, 55(1): 81-91.
5. Kearney M, Maldarelli F, Shao W, et al. HIV-1 population genetics and adaptation in newly infected individuals. J Virol, 2009, 83(6): 2715-2717.
6. Richter SS, Heilmann KP, Dohrn CL, et al. Changing epidemiology of antimicrobial-resistant streptococcus pneumoniae in the United States, 2004-2005. Clin Infect Dis, 2009, 48(3): e23-33.
7. Ogiso Y, Tomida A, Lei S, et al. Proteasome inhibition circumvents solid tumor resistance to topoisomerase II directed drugs. Cancer Res, 2000, 60(9): 2429-2434.
8. Polotti S, Collini P, Rilke F, et al. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of thyroid gland. J Pathol, 1994, 172(4): 337.
9. Wartenberg M, Gronczynska S, Bekhite MM, et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species. Int J Cancer, 2005, 113(2): 229-240.
10. Wartenberg M, DÖnmez F, Ling FC, et al. Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells. FASEB J, 2001, 15(6): 995-1005.
11. Comerford KM, Wallace TJ, Karhausen J, et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res, 2002, 62(12): 3387-3394. (Pubitemid 34651384)
12. Kool M, van der Linden M, de Haas M, et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA, 1999, 96(12): 6914-6919.
13. Cole SP, Deeley RG. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays, 1998, 20(11): 931-940. (Pubitemid 28554038)